[1]
Arun, N., Dev, A. and Singh, V.K. 2019. A Study on the Efficacy of 24 Weeks of Sofosbuvir, Daclatasvir with Ribaravin in the Treatment of Chronic Hepatitis C Patients with Cirrhosis, Genotype 1 and 3. Asian Journal of Medical Research. 7, 4 (Jan. 2019), ME25-ME28.